Xeltis
9 known investors
Find your way into Xeltis
Sign up to find every way you can get introduced to Xeltis
- Your email: who you already know at Xeltis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Xeltis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.
Founders & leadership
Investors · 9
How we know: Kurma Partners's portfolio page · Not right? Tell us
How we know: VI Partners's portfolio page · med-techinsights.com · funding news · Not right? Tell us
How we know: Ysios Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: med-techinsights.com · funding news · Not right? Tell us
How we know: med-techinsights.com · funding news · Not right? Tell us
Also in the syndicate · 3
In the news
Frequently asked questions
- What does Xeltis do?
- Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.
- Who are Xeltis's investors?
- Xeltis's investors include Kurma Partners, VI Partners, Ysios Capital, Amadeus Capital Partners, EQT Life Sciences, Invest-NL.





